Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTIQ Titration Regimens in Cancer Breakthrough Pain
NCT00236145Phase 3Completed
- Sponsor
- Cephalon, Inc.
- Start
- Jun 2004
- Primary completion
- Aug 2005
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of Painkyl in breakthrough pain, sponsored by Cephalon, Inc.. Started Jun 2004; status: completed.
02
Drugs
Painkyl
03
Conditions
breakthrough pain
Beyond the preview
Go deeper on NCT00236145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00236145.